Interview with Bormioli Pharma’s Andrea Lodetti at DCAT

Published on: 

Key Learning Objectives

  • Italy’s Bormioli Pharma grew North American sales of its leading glass and plastic packaging for injectable drugs by 40% in 2022 while mobilizing a multimillion dollar investment program to expand its parental drug packaging solutions
  • Celebrating its 200th anniversary, the company is pursuing ambitious “50-in-5” sustainability goals and commitments to alleviate industry supply chain shortages
  • Bormioli Pharma supplies customers with complete packaging solutions, including innovative glass and plastic bottles; plastic, rubber and aluminum closures; and accessories